Nuo Therapeutics, Inc. (AURX)
OTCMKTS · Delayed Price · Currency is USD
1.400
-0.050 (-3.45%)
Jul 11, 2025, 4:00 PM EDT

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2023 FY 2022 FY 2018 FY 2017 FY 2016
Period Ending
Dec '23 Dec '22 Dec '18 Dec '17 Dec '16
Innovative Cell-based Technologies
608.53K
Log In
Log In
Log In
Log In
Innovative Cell-based Technologies Growth
442.12%
Log In
Log In
Log In
Log In
License Fees
-
Log In
Log In
Log In
Log In
Product
-
Log In
Log In
Log In
Log In
Royalties
-
Log In
Log In
Log In
Log In

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2023 FY 2022 FY 2018 FY 2017 FY 2016
Period Ending
Dec '23 Dec '22 Dec '18 Dec '17 Dec '16
United States
608.53K
Log In
Log In
Log In
Log In
United States Growth
442.12%
Log In
Log In
Log In
Log In
International
-
Log In
Log In
Log In
Log In
International Growth
-
Log In
Log In
Log In
Log In